chaetoglobosins has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, L; Guo, Q; He, B; Song, W; Yin, Z; Zhang, J; Zhang, W; Zhang, Y | 1 |
| Curless, BP; Matesic, DF; Uko, NE | 1 |
| Ali, A; Matesic, DF; Sidorova, TS | 1 |
3 other study(ies) available for chaetoglobosins and Lung Neoplasms
| Article | Year |
|---|---|
Chaetoglobosin G inhibits proliferation, autophagy and cell cycle of lung cancer cells through EGFR/MEK/ERK signaling pathway.
Topics: A549 Cells; Apoptosis; Autophagy; Cell Proliferation; ErbB Receptors; Humans; Indole Alkaloids; Lung Neoplasms; MAP Kinase Signaling System; Signal Transduction | 2020 |
Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cells.
Topics: Adenocarcinoma of Lung; Apoptosis; Carcinogenesis; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Indole Alkaloids; Lung Neoplasms; Mechanistic Target of Rapamycin Complex 2; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Tumor Cells, Cultured | 2019 |
Dual modulation of JNK and Akt signaling pathways by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Epithelial Cells; Genes, ras; Humans; Indole Alkaloids; Lung Neoplasms; MAP Kinase Signaling System; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats | 2013 |